 1 Agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
 6 Agents against pathologic organisms and parasites
|
61 Antibiotics
|
62 Chemotherapeutics
|
621 Sulfonamides
|
622 Tuberculosis preparations
|
623 Leprostatics
|
624 Synthetic antibacterials
|
625 Antivirals
|
629 Miscellaneous
|
6290 Miscellaneous
|
 D00416 Miconazole (JP18/USP/INN)
D00282 Clotrimazole (JP18/USP/INN)
D00322 Fluconazole (JP18/USP/INN)
D01429 Fosfluconazole (JAN/INN)
D01980 Luliconazole (JAN/USAN/INN)
D10021 Efinaconazole (JAN/USAN/INN)
D02219 Terbinafine hydrochloride (JP18/USP)
D00323 Flucytosine (JP18/USP/INN)
D10762 Fosravuconazole L-lysine ethanolate (JAN)
D01995 Inosine pranobex (JAN)
D02500 Imiquimod (JAN/USP/INN)
D00285 Co-Trimoxazole (BAN)
D00350 Itraconazole (JP18/USP)
D00236 Atovaquone (JAN/USP/INN)
|
63 Biological preparations
|
64 Parasitics (systemic)
|
69 Other agents against pathogenic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan